| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.002 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |